Retrospective Study of the Relationship Between Human Papillomavirus Genotype and Cervical Epithelial Lesions
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Human papillomavirus (HPV) infection plays a key role in the carcinogenesis of cervical cancer and pre-invasive lesions. There are hundred types of HPV, including high risk and low risk types, and it is proved the close association between the cervical cancer and high risk HPV. While HPV 16 and 18 are known to be the leading two genotypes detected in women with cervical neoplasm worldwide, there is considerable difference in the other prevalent high risk genotypes in different geographic areas. It is important to establish the local database about the cervical intraepithelial lesions and the related prevalent HPV genotypes. The investigators designed a retrospective study which included total 784 patients managed at our hospital from January 1, 2000 to December 31, 2007. The present study was to investigate the HPV genotypes in the Taiwanese female patients with abnormal cervical cytology and analyses the association between HPV types and cervical pre-invasive lesions. It could provide the guide for the clinicians in the management of patients with abnormal cytological change of Pap smear.
| Condition |
|---|
|
Cervical Cancer |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Retrospective |
| Official Title: | Retrospective Study of the Relationship Between Human Papillomavirus Genotype and Cervical Epithelial Lesions |
- overall survival [ Time Frame: from disease diagnosis to death ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 800 |
| Study Start Date: | March 2009 |
| Estimated Study Completion Date: | December 2012 |
| Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 20 Years to 80 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
cervical cancer patients with HPVinfection
Inclusion Criteria:
- Healthy volunteers
- People infected with HPV type 16 but without CIN lesions
- Patients with CIN lesions
- Patients with cervical cancer from National Taiwan University Hospital
- Informed consent is obtained, and the protocols are reviewed and approved by the appropriate Investigative Review Boards.
Exclusion Criteria:
- None
Contacts and Locations| Contact: Wen-Fang Cheng, Associated Professor | 886-2-23123456 ext 65175 | wenfangcheng@yahoo.com |
| Taiwan | |
| National Taiwan University Hospital | Recruiting |
| Taipei, Taiwan | |
| Contact: wen-Fang Cheng, Associated Professor 886-2-23123456 ext 65175 wenfangcheng@yahoo.com | |
| Principal Investigator: | Wen-Fang Cheng | National Taiwan University Hospital |
More Information
No publications provided
| Responsible Party: | National Taiwan University Hospital |
| ClinicalTrials.gov Identifier: | NCT00872937 History of Changes |
| Other Study ID Numbers: | 200812138R |
| Study First Received: | March 30, 2009 |
| Last Updated: | May 16, 2012 |
| Health Authority: | Taiwan: Department of Health |
Additional relevant MeSH terms:
|
Uterine Cervical Neoplasms Uterine Neoplasms Genital Neoplasms, Female Urogenital Neoplasms Neoplasms by Site |
Neoplasms Uterine Cervical Diseases Uterine Diseases Genital Diseases, Female |
ClinicalTrials.gov processed this record on May 19, 2013